BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15661146)

  • 1. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
    Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
    Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C.
    Asselah T; Bièche I; Laurendeau I; Paradis V; Vidaud D; Degott C; Martinot M; Bedossa P; Valla D; Vidaud M; Marcellin P
    Gastroenterology; 2005 Dec; 129(6):2064-75. PubMed ID: 16344072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.
    Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Kaneko S
    Hepatology; 2006 Nov; 44(5):1122-38. PubMed ID: 17058214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma.
    Yamashita T; Kaneko S; Hashimoto S; Sato T; Nagai S; Toyoda N; Suzuki T; Kobayashi K; Matsushima K
    Biochem Biophys Res Commun; 2001 Mar; 282(2):647-54. PubMed ID: 11401510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.
    Patzwahl R; Meier V; Ramadori G; Mihm S
    J Virol; 2001 Feb; 75(3):1332-8. PubMed ID: 11152506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.
    Smith MW; Yue ZN; Korth MJ; Do HA; Boix L; Fausto N; Bruix J; Carithers RL; Katze MG
    Hepatology; 2003 Dec; 38(6):1458-67. PubMed ID: 14647057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
    Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
    Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus.
    Wald O; Pappo O; Safadi R; Dagan-Berger M; Beider K; Wald H; Franitza S; Weiss I; Avniel S; Boaz P; Hanna J; Zamir G; Eid A; Mandelboim O; Spengler U; Galun E; Peled A
    Eur J Immunol; 2004 Apr; 34(4):1164-74. PubMed ID: 15048728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury.
    Mihm S; Fayyazi A; Ramadori G
    Hepatology; 1997 Aug; 26(2):451-8. PubMed ID: 9252158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
    J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis.
    Lau DT; Luxon BA; Xiao SY; Beard MR; Lemon SM
    Hepatology; 2005 Aug; 42(2):273-81. PubMed ID: 15986378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
    Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.